Suppr超能文献

核β-抑制蛋白1是内皮素-1诱导的卵巢肿瘤进展中缺氧诱导因子-1α信号传导的关键辅助因子。

Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression.

作者信息

Cianfrocca Roberta, Tocci Piera, Rosanò Laura, Caprara Valentina, Sestito Rosanna, Di Castro Valeriana, Bagnato Anna

机构信息

Translational Research Functional Departmental Area, Regina Elena National Cancer Institute, Rome, Italy.

出版信息

Oncotarget. 2016 Apr 5;7(14):17790-804. doi: 10.18632/oncotarget.7461.

Abstract

Hypoxia-inducible factor-1α (HIF-1α) mediates the response to hypoxia or other stimuli, such as growth factors, including endothelin-1 (ET-1), to promote malignant progression in numerous tumors. The importance of cofactors that regulate HIF-1α signalling within tumor is not well understood. Here we elucidate that ET-1/ET(A) receptor (ET(A)R)-induced pathway physically and functionally couples the scaffold protein β-arrestin1 (β-arr1) to HIF-1α signalling. In epithelial ovarian cancer (EOC) cells, ET-1/ET(A)R axis induced vascular-endothelial growth factor (VEGF) expression through HIF-1α nuclear accumulation. In these cells, activation of ET(A)R by ET-1, by mimicking hypoxia, promoted the nuclear interaction between β-arr1 and HIF-1α and the recruitment of p300 acetyltransferase to hypoxia response elements on the target gene promoters, resulting in enhanced histone acetylation, and HIF-1α target gene transcription. Indeed, β-arr1-HIF-1α interaction regulated the enhanced expression and release of downstream targets, such as ET-1 and VEGF, required for tumor cell invasion and pro-angiogenic effects in endothelial cells. These effects were abrogated by β-arr1 or HIF-1α silencing or by pharmacological treatment with the dual ET-1 receptor antagonist macitentan. Interestingly, ET(A)R/β-arr1 promoted the self-amplifying HIF-1α-mediated transcription of ET-1 that sustained a regulatory circuit involved in invasive and angiogenic behaviors. In a murine orthotopic model of metastatic human EOC, treatment with macitentan, or silencing of β-arr1, inhibits intravasation and metastasis formation. Collectively, these findings reveal the interplay of β-arr1 with HIF-1α in the complexity of ET-1/ET(A)R signalling, mediating epigenetic modifications directly involved in the metastatic process, and suggest that targeting ET-1-dependent β-arr1/HIF-1α pathway by using macitentan may impair EOC progression.

摘要

缺氧诱导因子-1α(HIF-1α)介导细胞对缺氧或其他刺激(如生长因子,包括内皮素-1(ET-1))的反应,以促进多种肿瘤的恶性进展。肿瘤内调节HIF-1α信号传导的辅助因子的重要性尚未得到充分了解。在此,我们阐明ET-1/ET(A)受体(ET(A)R)诱导的信号通路在物理和功能上将支架蛋白β-抑制蛋白1(β-arr1)与HIF-1α信号传导联系起来。在上皮性卵巢癌(EOC)细胞中,ET-1/ET(A)R轴通过HIF-1α核积累诱导血管内皮生长因子(VEGF)表达。在这些细胞中,ET-1激活ET(A)R,通过模拟缺氧,促进β-arr1与HIF-1α之间的核相互作用以及p300乙酰转移酶募集到靶基因启动子上的缺氧反应元件,导致组蛋白乙酰化增强以及HIF-1α靶基因转录。实际上,β-arr1-HIF-1α相互作用调节下游靶点(如ET-1和VEGF)的表达增强和释放,这些靶点是肿瘤细胞侵袭和内皮细胞促血管生成作用所必需的。β-arr1或HIF-1α沉默或用双重ET-1受体拮抗剂马昔腾坦进行药物治疗可消除这些作用。有趣的是,ET(A)R/β-arr1促进了ET-1的自扩增HIF-1α介导的转录,维持了一个涉及侵袭和血管生成行为的调节回路。在转移性人EOC的小鼠原位模型中,用马昔腾坦治疗或沉默β-arr1可抑制肿瘤细胞内渗和转移形成。总的来说,这些发现揭示了β-arr1与HIF-1α在ET-1/ET(A)R信号复杂性中的相互作用,介导了直接参与转移过程的表观遗传修饰,并表明使用马昔腾坦靶向ET-1依赖性β-arr1/HIF-1α途径可能会损害EOC的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8568/4951250/53347d7623ee/oncotarget-07-17790-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验